
Cedilla Therapeutics
Harnessing intrinsic protein stability mechanisms to develop small molecule therapeutics for cancer and protein dysregulation diseases.
Employees
Enterprise value
$288m
Authorizing premium user...
Harnessing intrinsic protein stability mechanisms to develop small molecule therapeutics for cancer and protein dysregulation diseases.